Rare Disease Therapeutics, Inc Company Profile
✉ Email this page to a colleague
Biologic Drugs for Rare Disease Therapeutics, Inc
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Rare Disease Therapeutics, Inc. (rdt) | ANASCORP | centruroides (scorpion) immune f(ab')2 (equine) injection | For Injection | 125335 | 6,365,160 | 2016-07-26 | DrugPatentWatch analysis and company disclosures |
| Rare Disease Therapeutics, Inc. (rdt) | ANASCORP | centruroides (scorpion) immune f(ab')2 (equine) injection | For Injection | 125335 | 6,436,400 | 2020-01-07 | DrugPatentWatch analysis and company disclosures |
| Rare Disease Therapeutics, Inc. (rdt) | ANASCORP | centruroides (scorpion) immune f(ab')2 (equine) injection | For Injection | 125335 | 6,656,488 | 2021-04-11 | DrugPatentWatch analysis and company disclosures |
| Rare Disease Therapeutics, Inc. (rdt) | ANASCORP | centruroides (scorpion) immune f(ab')2 (equine) injection | For Injection | 125335 | 6,709,655 | 2021-02-28 | DrugPatentWatch analysis and company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.
